Sign up to save your podcasts
Or
Share Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer
Gopa Iyer from MSKCC joins the show to discuss his initial results from this phase 2 trial.
View all episodes
By The Uromigos
4.9
5555 ratings
Gopa Iyer from MSKCC joins the show to discuss his initial results from this phase 2 trial.
More shows like The Uromigos
View all
JAMA Editors' Summary
135 Listeners
Prostate Cancer Update
14 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
502 Listeners
AFP: American Family Physician Podcast
693 Listeners
ASCO Daily News
59 Listeners
White Coat Investor Podcast
2,426 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
The Peter Attia Drive
8,021 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
519 Listeners
GU Cast | Urology Podcast
2 Listeners
BioCentury This Week
30 Listeners
Two Onc Docs
181 Listeners
The View on GU | with Lalani and Wallis
2 Listeners